Skip to main content
Erschienen in: Supportive Care in Cancer 4/2019

15.08.2018 | Original Article

Breast Cancer Collaborative Registry informs understanding of factors predicting sleep quality

verfasst von: Ann M. Berger, Kevin A. Kupzyk, Dilorom M. Djalilova, Kenneth H. Cowan

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Significance

Poor sleep quality is a common and persistent problem reported by women with breast cancer (BC). Empirical evidence identifies many risk factors for self-reported sleep deficiency, but inconsistencies limit translation to practice.

Purpose

To increase understanding of risk factors predicting self-reported poor sleep quality in women with BC who completed the Breast Cancer Collaborative Registry (BCCR) questionnaire.

Methods

This cross-sectional study recruited women with a first diagnosis of BC (n = 1302) at five sites in Nebraska and South Dakota. Women completed the BCCR that includes numerous variables as well as the Pittsburgh Sleep Quality Index (PSQI) and SF36v2 (n = 1260). Descriptive statistics and non-parametric correlations were used to determine associations and create predictive models of sleep quality with BCCR variables and SF36v2 subscales.

Results

Most women were white (93.7%) and married (71.5%); mean age was 60.1 (21–90) years. Poor sleep was self-reported by 53% of women. Seven variables were highly associated with sleep quality (p ≤ 0.001). The first model found younger age, lower physical activity, and higher fatigue were the strongest combined and independent variables predicting poor sleep quality (F = 23.0 (p < .001), R2 = 0.103). Participants self-reported lower health status on most SF36v2 subscales [Z = 44.9 (11.6) to 49.1 (10.1)]. A second model found that all subscales were predictors of poor sleep; vitality, mental health, bodily pain, and general health were the strongest predictors (F = 101.3 (p < .001), R2 = 0.26).

Conclusions

Results confirm previously identified risk factors and reveal inconsistencies in other variables. Clinicians need to routinely screen for the identified risk factors of self-reported poor sleep quality.
Literatur
1.
Zurück zum Zitat Palesh O, Roscoe J, Mustian KM et al (2010) Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol 28:292–298CrossRefPubMed Palesh O, Roscoe J, Mustian KM et al (2010) Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol 28:292–298CrossRefPubMed
2.
Zurück zum Zitat Sanford SD, Wagner LI, Beaumont JL, Butt Z, Sweet JJ, Cella D (2013) Longitudinal prospective assessment of sleep quality: before, during, and after adjuvant chemotherapy for breast cancer. Support Care Cancer 21:959–967CrossRefPubMed Sanford SD, Wagner LI, Beaumont JL, Butt Z, Sweet JJ, Cella D (2013) Longitudinal prospective assessment of sleep quality: before, during, and after adjuvant chemotherapy for breast cancer. Support Care Cancer 21:959–967CrossRefPubMed
4.
Zurück zum Zitat Savard J, Ivers H, Savard MH, Morin CM (2015) Cancer treatments and their side effects are associated with aggravation of insomnia: results of a longitudinal study. Cancer 121:1703–1711CrossRefPubMed Savard J, Ivers H, Savard MH, Morin CM (2015) Cancer treatments and their side effects are associated with aggravation of insomnia: results of a longitudinal study. Cancer 121:1703–1711CrossRefPubMed
5.
Zurück zum Zitat Fontes F, Pereira S, Costa AR, Gonçalves M, Lunet N (2017) The impact of breast cancer treatments on sleep quality 1 year after cancer diagnosis. Support Care Cancer 25:3529–3536CrossRefPubMed Fontes F, Pereira S, Costa AR, Gonçalves M, Lunet N (2017) The impact of breast cancer treatments on sleep quality 1 year after cancer diagnosis. Support Care Cancer 25:3529–3536CrossRefPubMed
6.
Zurück zum Zitat Irwin MR (2013) Depression and insomnia in cancer: prevalence, risk factors, and effects on cancer outcomes. Curr Psychiatry Rep 15:404–404CrossRefPubMed Irwin MR (2013) Depression and insomnia in cancer: prevalence, risk factors, and effects on cancer outcomes. Curr Psychiatry Rep 15:404–404CrossRefPubMed
7.
Zurück zum Zitat Liu L, Fiorentino L, Rissling M, Natarajan L, Parker BA, Dimsdale JE, Mills PJ, Sadler GR, Ancoli-Israel S (2013) Decreased health-related quality of life in women with breast cancer is associated with poor sleep. Behav Sleep Med 11:189–206CrossRefPubMed Liu L, Fiorentino L, Rissling M, Natarajan L, Parker BA, Dimsdale JE, Mills PJ, Sadler GR, Ancoli-Israel S (2013) Decreased health-related quality of life in women with breast cancer is associated with poor sleep. Behav Sleep Med 11:189–206CrossRefPubMed
8.
Zurück zum Zitat Buysse D, Reynolds CF 3rd, Monk TH et al (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213CrossRefPubMed Buysse D, Reynolds CF 3rd, Monk TH et al (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213CrossRefPubMed
9.
Zurück zum Zitat Buysse D, Reynolds CF 3rd, Monk TH et al (1991) Quantification of subjective sleep quality in healthy elderly men and women using the Pittsburgh Sleep Quality Index (PSQI). Sleep 14:331–338PubMed Buysse D, Reynolds CF 3rd, Monk TH et al (1991) Quantification of subjective sleep quality in healthy elderly men and women using the Pittsburgh Sleep Quality Index (PSQI). Sleep 14:331–338PubMed
10.
Zurück zum Zitat Backhaus J, Junghanns K, Broocks A, Riemann D, Hohagen F (2002) Test–retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res 53:737–740CrossRefPubMed Backhaus J, Junghanns K, Broocks A, Riemann D, Hohagen F (2002) Test–retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res 53:737–740CrossRefPubMed
11.
Zurück zum Zitat Bush AL, Armento ME, Weiss BJ et al (2012) The Pittsburgh Sleep Quality Index in older primary care patients with generalized anxiety disorder: psychometrics and outcomes following cognitive behavioral therapy. Psychiatry Res 199:24–30CrossRefPubMedPubMedCentral Bush AL, Armento ME, Weiss BJ et al (2012) The Pittsburgh Sleep Quality Index in older primary care patients with generalized anxiety disorder: psychometrics and outcomes following cognitive behavioral therapy. Psychiatry Res 199:24–30CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Beck SL, Schwartz AL, Towsley G, Dudley W, Barsevick A (2004) Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. J Pain Symptom Manag 27:140–148CrossRef Beck SL, Schwartz AL, Towsley G, Dudley W, Barsevick A (2004) Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. J Pain Symptom Manag 27:140–148CrossRef
13.
Zurück zum Zitat Beck SL, Berger A, Barsevick A et al (2010) Sleep quality after initial chemotherapy for breast cancer. Support Care Cancer 18:679–689CrossRefPubMed Beck SL, Berger A, Barsevick A et al (2010) Sleep quality after initial chemotherapy for breast cancer. Support Care Cancer 18:679–689CrossRefPubMed
14.
Zurück zum Zitat Colagiuri B, Christensen S, Jensen AB, Price MA, Butow PN, Zachariae R (2011) Prevalence and predictors of sleep difficulty in a national cohort of women with primary breast cancer three to four months postsurgery. J Pain Symptom Manag 42:710–720CrossRef Colagiuri B, Christensen S, Jensen AB, Price MA, Butow PN, Zachariae R (2011) Prevalence and predictors of sleep difficulty in a national cohort of women with primary breast cancer three to four months postsurgery. J Pain Symptom Manag 42:710–720CrossRef
15.
Zurück zum Zitat Otte JL, Carpenter JS, Russell KM, Bigatti S, Champion VL (2010) Prevalence, severity, and correlates of sleep-wake disturbances in long-term breast cancer survivors. J Pain Symptom Manag 39:535–547CrossRef Otte JL, Carpenter JS, Russell KM, Bigatti S, Champion VL (2010) Prevalence, severity, and correlates of sleep-wake disturbances in long-term breast cancer survivors. J Pain Symptom Manag 39:535–547CrossRef
16.
Zurück zum Zitat Mark S, Cataldo J, Dhruva A, Paul SM, Chen LM, Hammer MJ, Levine JD, Wright F, Melisko M, Lee K, Conley YP, Miaskowski C (2017) Modifiable and non-modifiable characteristics associated with sleep disturbance in oncology outpatients during chemotherapy. Support Care Cancer 25:2485–2494CrossRefPubMedPubMedCentral Mark S, Cataldo J, Dhruva A, Paul SM, Chen LM, Hammer MJ, Levine JD, Wright F, Melisko M, Lee K, Conley YP, Miaskowski C (2017) Modifiable and non-modifiable characteristics associated with sleep disturbance in oncology outpatients during chemotherapy. Support Care Cancer 25:2485–2494CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Visovsky C, Berger A, Hertzog M et al (2014) Breast cancer collaborative registry: comparison of physical and mental health and sleep in breast cancer survivors. JONS 5:29–38 Visovsky C, Berger A, Hertzog M et al (2014) Breast cancer collaborative registry: comparison of physical and mental health and sleep in breast cancer survivors. JONS 5:29–38
18.
Zurück zum Zitat Klyushnenkova EN, Sorkin JD, Gallicchio L (2015) Association of obesity and sleep problems among breast cancer survivors: results from a registry-based survey study. Support Care Cancer 23:3437–3445CrossRefPubMedPubMedCentral Klyushnenkova EN, Sorkin JD, Gallicchio L (2015) Association of obesity and sleep problems among breast cancer survivors: results from a registry-based survey study. Support Care Cancer 23:3437–3445CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Tian L, Lin L, Li HL, Chen KJ, Zhang XJ, Qian SJ, Hu Y (2016) Prevalence and associated factors of cancer-related fatigue among cancer patients in Eastern China. Oncologist 21:1349–1354CrossRefPubMedPubMedCentral Tian L, Lin L, Li HL, Chen KJ, Zhang XJ, Qian SJ, Hu Y (2016) Prevalence and associated factors of cancer-related fatigue among cancer patients in Eastern China. Oncologist 21:1349–1354CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Vargas S, Wohlgemuth WK, Antoni MH et al (2010) Sleep dysfunction and psychosocial adaptation among women undergoing treatment for non-metastatic breast cancer. Psycho-Oncol 19:669–673CrossRef Vargas S, Wohlgemuth WK, Antoni MH et al (2010) Sleep dysfunction and psychosocial adaptation among women undergoing treatment for non-metastatic breast cancer. Psycho-Oncol 19:669–673CrossRef
21.
Zurück zum Zitat Bower J, Ganz PA, Irwin MR et al (2011) Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol 29:3517–3522CrossRefPubMedPubMedCentral Bower J, Ganz PA, Irwin MR et al (2011) Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol 29:3517–3522CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Overcash J, Tan A, Patel K, Noonan A (2018) Factors associated with poor sleep in older women diagnosed with breast cancer. Oncol Nurs Forum 45:359–371CrossRefPubMed Overcash J, Tan A, Patel K, Noonan A (2018) Factors associated with poor sleep in older women diagnosed with breast cancer. Oncol Nurs Forum 45:359–371CrossRefPubMed
23.
Zurück zum Zitat Chiu HY, Huang HC, Chen PY, Hou WH, Tsai PS (2015) Walking improves sleep in individuals with cancer: a meta-analysis of randomized, controlled trials. Oncol Nurs Forum 42:E54–E62CrossRefPubMed Chiu HY, Huang HC, Chen PY, Hou WH, Tsai PS (2015) Walking improves sleep in individuals with cancer: a meta-analysis of randomized, controlled trials. Oncol Nurs Forum 42:E54–E62CrossRefPubMed
24.
Zurück zum Zitat Rogers LQ, Fogleman A, Trammell R, Hopkins-Price P, Spenner A, Vicari S, Rao K, Courneya KS, Hoelzer K, Robbs R, Verhulst S (2015) Inflammation and psychosocial factors mediate exercise effects on sleep quality in breast cancer survivors: pilot randomized controlled trial. Psycho-Oncol 24:302–310CrossRef Rogers LQ, Fogleman A, Trammell R, Hopkins-Price P, Spenner A, Vicari S, Rao K, Courneya KS, Hoelzer K, Robbs R, Verhulst S (2015) Inflammation and psychosocial factors mediate exercise effects on sleep quality in breast cancer survivors: pilot randomized controlled trial. Psycho-Oncol 24:302–310CrossRef
25.
Zurück zum Zitat Matthews E, Carter P, Page M, Dean G, Berger A (2018) Sleep-wake disturbance: a systematic review of evidence-based interventions for management in patients with cancer. Clin J Oncol Nurs 22:37–52CrossRefPubMed Matthews E, Carter P, Page M, Dean G, Berger A (2018) Sleep-wake disturbance: a systematic review of evidence-based interventions for management in patients with cancer. Clin J Oncol Nurs 22:37–52CrossRefPubMed
26.
Zurück zum Zitat Dhruva A, Paul SM, Cooper BA, Lee K, West C, Aouizerat BE, Dunn LB, Swift PS, Wara W, Miaskowski C (2012) A longitudinal study of measures of objective and subjective sleep disturbance in patients with breast cancer before, during, and after radiation therapy. J Pain Symptom Manag 44:215–228CrossRef Dhruva A, Paul SM, Cooper BA, Lee K, West C, Aouizerat BE, Dunn LB, Swift PS, Wara W, Miaskowski C (2012) A longitudinal study of measures of objective and subjective sleep disturbance in patients with breast cancer before, during, and after radiation therapy. J Pain Symptom Manag 44:215–228CrossRef
27.
Zurück zum Zitat Sherman S, Shats O, Fleissner E, Bascom G, Yiee K, Copur M, Crow K, Rooney J, Mateen Z, Ketcham MA, Feng J, Sherman A, Gleason M, Kinarsky L, Silva-Lopez E, Edney J, Reed E, Berger A, Cowan K (2011) Multicenter breast cancer collaborative registry. Cancer Inform 10:217–226PubMedPubMedCentral Sherman S, Shats O, Fleissner E, Bascom G, Yiee K, Copur M, Crow K, Rooney J, Mateen Z, Ketcham MA, Feng J, Sherman A, Gleason M, Kinarsky L, Silva-Lopez E, Edney J, Reed E, Berger A, Cowan K (2011) Multicenter breast cancer collaborative registry. Cancer Inform 10:217–226PubMedPubMedCentral
28.
Zurück zum Zitat Ware JE, Kosinski M, Dewey JE (2000) How to score version 2 of the SF-36® Health Survey. QualityMetric Incorporated, Lincoln Ware JE, Kosinski M, Dewey JE (2000) How to score version 2 of the SF-36® Health Survey. QualityMetric Incorporated, Lincoln
29.
Zurück zum Zitat Fontes F, Severo M, Goncalves M et al (2017) Trajectories of sleep quality during the first three years after breast cancer diagnosis. Sleep Med 34:193–199CrossRefPubMed Fontes F, Severo M, Goncalves M et al (2017) Trajectories of sleep quality during the first three years after breast cancer diagnosis. Sleep Med 34:193–199CrossRefPubMed
30.
31.
Zurück zum Zitat Henneghan AM, Carter P, Stuifbergan A, Parmelee B, Kesler S (2018) Relationships between self-reported sleep quality components and cognitive functioning in breast cancer survivors up to 10 years following chemotherapy. Psycho-Oncol 27:1937–1943. https://doi.org/10.1002/pon.4745 CrossRef Henneghan AM, Carter P, Stuifbergan A, Parmelee B, Kesler S (2018) Relationships between self-reported sleep quality components and cognitive functioning in breast cancer survivors up to 10 years following chemotherapy. Psycho-Oncol 27:1937–1943. https://​doi.​org/​10.​1002/​pon.​4745 CrossRef
32.
Zurück zum Zitat Donovan KA, Boyington AR, Ismail-Khan R, Wyman JF (2012) Urinary symptoms in breast cancer: a systematic review. Cancer 118:582–593CrossRefPubMed Donovan KA, Boyington AR, Ismail-Khan R, Wyman JF (2012) Urinary symptoms in breast cancer: a systematic review. Cancer 118:582–593CrossRefPubMed
33.
Zurück zum Zitat Berger AM, Lockhart K, Agrawal S (2009) Variability of patterns of fatigue and quality of life over time based on different breast cancer adjuvant chemotherapy regimens. Oncol Nurs Forum 36:563–570CrossRefPubMed Berger AM, Lockhart K, Agrawal S (2009) Variability of patterns of fatigue and quality of life over time based on different breast cancer adjuvant chemotherapy regimens. Oncol Nurs Forum 36:563–570CrossRefPubMed
34.
Zurück zum Zitat Tiezzi MF, da Mata B, de Andrade JM, Romão AP, Salata M et al (2016) Quality of life in women with breast cancer treated with or without chemotherapy. Cancer Nurs 40:108–116CrossRef Tiezzi MF, da Mata B, de Andrade JM, Romão AP, Salata M et al (2016) Quality of life in women with breast cancer treated with or without chemotherapy. Cancer Nurs 40:108–116CrossRef
35.
Zurück zum Zitat Hofsø K, Rustøen T, Cooper BA, Bjordal K, Miaskowski C (2013) Changes over time in occurrence, severity, and distress of common symptoms during and after radiation therapy for breast cancer. J Pain Symptom Manag 45:980–1006CrossRef Hofsø K, Rustøen T, Cooper BA, Bjordal K, Miaskowski C (2013) Changes over time in occurrence, severity, and distress of common symptoms during and after radiation therapy for breast cancer. J Pain Symptom Manag 45:980–1006CrossRef
36.
Zurück zum Zitat Alfano CM, Lichstein K, Vander Wal GS et al (2011) Sleep duration change across breast cancer survivorship: associations with symptoms and health-related quality of life. Breast Cancer Res Treat 130:243–254CrossRefPubMedPubMedCentral Alfano CM, Lichstein K, Vander Wal GS et al (2011) Sleep duration change across breast cancer survivorship: associations with symptoms and health-related quality of life. Breast Cancer Res Treat 130:243–254CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Mercadante S, Adile C, Ferrera P, Masedu F, Valenti M, Aielli F (2017) Sleep disturbances in advanced cancer patients admitted to a supportive/palliative care unit. Support Care Cancer 25:1301–1306CrossRefPubMed Mercadante S, Adile C, Ferrera P, Masedu F, Valenti M, Aielli F (2017) Sleep disturbances in advanced cancer patients admitted to a supportive/palliative care unit. Support Care Cancer 25:1301–1306CrossRefPubMed
38.
Zurück zum Zitat Mosher CE, DuHamel KN (2012) An examination of distress, sleep, and fatigue in metastatic breast cancer patients. Psycho-Oncol 21:100–107CrossRef Mosher CE, DuHamel KN (2012) An examination of distress, sleep, and fatigue in metastatic breast cancer patients. Psycho-Oncol 21:100–107CrossRef
39.
Zurück zum Zitat Delgado-Guay M, Yennurajalingam S, Parsons H, Palmer JL, Bruera E (2011) Association between self-reported sleep disturbance and other symptoms in patients with advanced cancer. J Pain Symptom Manag 41:819–827CrossRef Delgado-Guay M, Yennurajalingam S, Parsons H, Palmer JL, Bruera E (2011) Association between self-reported sleep disturbance and other symptoms in patients with advanced cancer. J Pain Symptom Manag 41:819–827CrossRef
40.
Zurück zum Zitat Miaskowski C, Barsevick A, Berger A et al (2017) Advancing symptom science through symptom cluster research: expert panel proceedings and recommendations. J Natl Cancer Inst 109:1–9CrossRef Miaskowski C, Barsevick A, Berger A et al (2017) Advancing symptom science through symptom cluster research: expert panel proceedings and recommendations. J Natl Cancer Inst 109:1–9CrossRef
41.
Zurück zum Zitat Syrowatka A, Motulsky A, Kurteva S, Hanley JA, Dixon WG, Meguerditchian AN, Tamblyn R (2017) Predictors of distress in female breast cancer survivors: a systematic review. Breast Cancer Res Treat 165:229–245CrossRefPubMedPubMedCentral Syrowatka A, Motulsky A, Kurteva S, Hanley JA, Dixon WG, Meguerditchian AN, Tamblyn R (2017) Predictors of distress in female breast cancer survivors: a systematic review. Breast Cancer Res Treat 165:229–245CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Craig BM, Reeve BB, Brown PM, Cella D, Hays RD, Lipscomb J, Simon Pickard A, Revicki DA (2014) US valuation of health outcomes measured using the PROMIS-29. Value Health 17:846–853CrossRefPubMedPubMedCentral Craig BM, Reeve BB, Brown PM, Cella D, Hays RD, Lipscomb J, Simon Pickard A, Revicki DA (2014) US valuation of health outcomes measured using the PROMIS-29. Value Health 17:846–853CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Cleeland C, Mendoza TR, Wang XS et al (2000) Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer 89:1634–1646CrossRefPubMed Cleeland C, Mendoza TR, Wang XS et al (2000) Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer 89:1634–1646CrossRefPubMed
44.
Zurück zum Zitat Johnson JA, Rash JA, Campbell TS et al (2016) A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors. Sleep Med Reviews 27:20–28 Johnson JA, Rash JA, Campbell TS et al (2016) A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors. Sleep Med Reviews 27:20–28
Metadaten
Titel
Breast Cancer Collaborative Registry informs understanding of factors predicting sleep quality
verfasst von
Ann M. Berger
Kevin A. Kupzyk
Dilorom M. Djalilova
Kenneth H. Cowan
Publikationsdatum
15.08.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2019
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4417-5

Weitere Artikel der Ausgabe 4/2019

Supportive Care in Cancer 4/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.